Fig 1.

Adverse events to BNT162b2 mRNA COVID‐19 vaccine reported in patients diagnosed with multiple myeloma (MM) versus healthy controls. [Colour figure can be viewed at wileyonlinelibrary.com]

Adverse events to BNT162b2 mRNA COVID‐19 vaccine reported in patients diagnosed with multiple myeloma (MM) versus healthy controls. [Colour figure can be viewed at wileyonlinelibrary.com]